drugset / Trial / NCT00153114

PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children

NCT00153114

Phase 4 Completed 100 enrolled Braintree Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

Assess the safety and efficacy of polyethyleneglycol3350 laxative as compared to placebo therapy in pediatric patients with a history of constipation.

Timeline

Start
2003-01
Primary completion
2004-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject polyethylene glycol Other / unclassified

Indications